Literature DB >> 17590442

Blocking lymphotoxin beta receptor signalling exacerbates acute DSS-induced intestinal inflammation--opposite functions for surface lymphotoxin expressed by T and B lymphocytes.

Michaela Jungbeck1, Peter Stopfer, Frauke Bataille, Sergei A Nedospasov, Daniela N Männel, Thomas Hehlgans.   

Abstract

The lymphotoxin beta receptor (LTbetaR) signalling pathway is involved in the development of secondary lymphoid organs and the maintenance of organized lymphoid tissues. Additionally, previous studies clearly demonstrated the involvement of the LTbetaR interaction with its ligands in promoting intestinal inflammation. In order to dissect the role of LTbetaR activation in the mouse model of acute DSS-induced colitis we treated mice with a functional inhibitor of LTbetaR activation (LTbetaR:Ig) and compared it to disease in LTbetaR-deficient and LTalphabeta-deficient mice. All these modes of LTbetaR signalling ablation resulted in significant aggravation of the disease and in release of inflammatory cytokines such as TNF, IL-6, and IFNgamma. Finally, using mice with conditionally ablated expression of membrane bound LTbeta on T or B cells, respectively, distinct and opposite contributions of surface LTbeta expressed on T or B cells was found. Thus, activation of LTbetaR by LTalphabeta mainly expressed on T lymphocytes is crucial for the down regulation of the inflammatory response in this experimental model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17590442     DOI: 10.1016/j.molimm.2007.05.007

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  11 in total

Review 1.  Regulating the mucosal immune system: the contrasting roles of LIGHT, HVEM, and their various partners.

Authors:  Marcos W Steinberg; Jr-Wen Shui; Carl F Ware; Mitchell Kronenberg
Journal:  Semin Immunopathol       Date:  2009-06-03       Impact factor: 9.623

2.  Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease.

Authors:  Eugene Y Chiang; Ganesh A Kolumam; Xin Yu; Michelle Francesco; Sinisa Ivelja; Ivan Peng; Peter Gribling; Jean Shu; Wyne P Lee; Canio J Refino; Mercedesz Balazs; Andres Paler-Martinez; Allen Nguyen; Judy Young; Kai H Barck; Richard A D Carano; Ron Ferrando; Lauri Diehl; Devavani Chatterjea; Jane L Grogan
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

3.  Tumor necrosis factor receptor 1 functions as a tumor suppressor.

Authors:  Fengqi Chang; Michelle R Lacey; Mostafa Bouljihad; Kerstin Höner Zu Bentrup; Ilana S Fortgang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-11-03       Impact factor: 4.052

4.  Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge.

Authors:  Alexei V Tumanov; Ekaterina P Koroleva; Xiaohuan Guo; Yugang Wang; Andrei Kruglov; Sergei Nedospasov; Yang-Xin Fu
Journal:  Cell Host Microbe       Date:  2011-07-21       Impact factor: 21.023

5.  Induction and activation of adaptive immune populations during acute and chronic phases of a murine model of experimental colitis.

Authors:  Lindsay J Hall; Emilie Faivre; Aoife Quinlan; Fergus Shanahan; Kenneth Nally; Silvia Melgar
Journal:  Dig Dis Sci       Date:  2010-05-14       Impact factor: 3.199

6.  Neutralization of LIGHT ameliorates acute dextran sodium sulphate-induced intestinal inflammation.

Authors:  Michaela Jungbeck; Barbara Daller; Josef Federhofer; Anja K Wege; Nadin Wimmer; Daniela N Männel; Thomas Hehlgans
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

7.  Lymphotoxin beta receptor signaling limits mucosal damage through driving IL-23 production by epithelial cells.

Authors:  E Macho-Fernandez; E P Koroleva; C M Spencer; M Tighe; E Torrado; A M Cooper; Y-X Fu; A V Tumanov
Journal:  Mucosal Immunol       Date:  2014-09-03       Impact factor: 7.313

8.  The Tumor Necrosis Factor Superfamily Members TNFSF14 (LIGHT), Lymphotoxin β and Lymphotoxin β Receptor Interact to Regulate Intestinal Inflammation.

Authors:  Daniel A Giles; Sonja Zahner; Petra Krause; Esmé Van Der Gracht; Thomas Riffelmacher; Venetia Morris; Alexei Tumanov; Mitchell Kronenberg
Journal:  Front Immunol       Date:  2018-11-22       Impact factor: 7.561

9.  An epithelial Nfkb2 pathway exacerbates intestinal inflammation by supplementing latent RelA dimers to the canonical NF-κB module.

Authors:  Meenakshi Chawla; Tapas Mukherjee; Alvina Deka; Budhaditya Chatterjee; Uday Aditya Sarkar; Amit K Singh; Saurabh Kedia; Josephine Lum; Manprit Kaur Dhillon; Balaji Banoth; Subhra K Biswas; Vineet Ahuja; Soumen Basak
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-22       Impact factor: 11.205

10.  β7-Integrin exacerbates experimental DSS-induced colitis in mice by directing inflammatory monocytes into the colon.

Authors:  A Schippers; M Muschaweck; T Clahsen; S Tautorat; L Grieb; K Tenbrock; N Gaßler; N Wagner
Journal:  Mucosal Immunol       Date:  2015-09-09       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.